[Relative bioavailability of 2 commercial preparations of aspirin]. 1986

S Cedillo Vaz, and R Naranjo, and A V de Vicuña

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012459 Salicylates The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis. Salicylate,Salicylic Acids,Acids, Salicylic

Related Publications

S Cedillo Vaz, and R Naranjo, and A V de Vicuña
December 1981, Journal of pharmaceutical sciences,
S Cedillo Vaz, and R Naranjo, and A V de Vicuña
June 1975, Journal of pharmaceutical sciences,
S Cedillo Vaz, and R Naranjo, and A V de Vicuña
March 1986, Clinical pharmacy,
S Cedillo Vaz, and R Naranjo, and A V de Vicuña
December 2001, Magnesium research,
S Cedillo Vaz, and R Naranjo, and A V de Vicuña
January 1981, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
S Cedillo Vaz, and R Naranjo, and A V de Vicuña
January 1980, Biopharmaceutics & drug disposition,
S Cedillo Vaz, and R Naranjo, and A V de Vicuña
November 1973, Canadian Medical Association journal,
S Cedillo Vaz, and R Naranjo, and A V de Vicuña
August 1983, Journal of pharmaceutical sciences,
S Cedillo Vaz, and R Naranjo, and A V de Vicuña
January 1988, The Journal of international medical research,
S Cedillo Vaz, and R Naranjo, and A V de Vicuña
July 1979, European journal of clinical pharmacology,
Copied contents to your clipboard!